The recurrence rates of curettage alone are comparable to that of curettage with electrodessication in patients with keratinocyte carcinoma.

Galderma is a pure-play dermatology company, with a leadership position in the self-care segment of the market, with more than 90% of total sales paid by consumers out of pocket. Its long-term revenue ...

Anti-CGRP monoclonal antibody therapy in patients with migraine can reduce headache burden and stabilize retinal and optic nerve changes.

Discover how K-beauty is evolving with biotech-powered skincare. Brands like GLASSFX use cutting-edge ingredients and barrier ...

For the treatment of bacterial keratitis, adjunctive corticosteroids are not superior to placebo and adjunctive corneal cross-linking (CXL) is associated with increased scar size, according to a study ...

The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...

LENZ Therapeutics previously licensed Greater China rights to CORXEL for the development and commercialization of LNZ100 in April 2022.

Neither corticosteroids nor corneal crosslinking improve outcomes when added to standard bacterial keratitis therapy.

Viatris’ investigational blepharitis ointment failed to achieve the primary endpoint in its Phase III trial, prompting the ...

The best exfoliating body washes do more than cleanse—they smooth out rough skin using a blend of chemical or physical exfoliants and barrier-supporting ingredients. Whether you’re dealing with ...

The FDA granted fast track designation to SAR446597, an intravitreal gene therapy for the treatment of geographic atrophy due ...

HAE attacks can now be treated with a pill, Ekterly (sebetralstat), instead by injection or infusion. That could translate to faster symptom relief.